Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.


Boosting pharma’s metabolic rate

Boosting pharma’s metabolic rate Biopharma company UCB is a good example of an organisation that has made patient-centricity a reality at the core of the business.

Bayer UK and Ireland appoints new CEO

Bayer UK and Ireland appoints new CEO Bruening succeeds Alexander Moscho, who left Bayer after seven years to join  UCB as its chief strategy officer.

UCB’s antiepileptic drug gains new US indication

UCB’s antiepileptic drug gains new US indication Epilepsy is currently the fourth most common neurological condition worldwide and affects approximately 65 million people, according to UCB. ... Wren concluded: “Discovering, validating and improving access to new and innovative solutions to support

Ian Weatherhead joins Ipsen

Ian Weatherhead joins Ipsen Prior to that he held global, regional and affiliate roles with AstraZeneca, Syngenta, UCB and Sanofi.

UCB collaborates with UK's Medical Research Council

UCB collaborates with UK's Medical Research Council The partners will support researchers developing antibody-based therapeutics. UCB has teamed up with the UK’s Medical Research Council (MRC) to support academic researchers in their work to develop a ... Neil Weir, head of discovery research at UCB,

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...